QRS aberration during atrial fibrillation at rest and during exercise. Effect of a selective potassium channel blocking agent

Journal of Electrocardiology

Volumn 35, Issue 3, 2002, Pages 201-212

  Houltz, Birgitta ^a,b,c,d,e,f   Darpö, Börje ^a,b,c,d,e,f   Crijns, Harry J G M ^a,b,c,d,e,f   Swedberg, Karl ^a,b,c,d,e,f   Blomström, Per ^a,b,c,d,e,f   Jensen, Steen M ^a,b,c,d,e,f   Svernhage, Elisabeth ^a,b,c,d,e,f   Edvardsson, Nils ^a,b,c,d,e,f  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^e UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^f ASTRAZENECA R AND D   (Sweden)

Author keywords

Aberrant conduction; Atrial fibrillation; Potassium channel blockers; Proarrhythmia; Torsades de pointes; Ventricular repolarization

Indexed keywords

ALMOKALANT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIGITALIS; DIURETIC AGENT; POTASSIUM CHANNEL BLOCKING AGENT;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; EXERCISE; EXTRASYSTOLE; FEMALE; HEART ATRIUM FIBRILLATION; HEART BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE CONDUCTION DISTURBANCE; HEART REPOLARIZATION; HEART SUPRAVENTRICULAR ARRHYTHMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MYOCARDIAL DISEASE; PRIORITY JOURNAL; PROBABILITY; QRS COMPLEX; REST; SINUS RHYTHM;

EID: 0036074077     PISSN: 00220736     EISSN: None     Source Type: Journal    
DOI: 10.1054/jelc.2002.33766     Document Type: Article

References (29)

1. Supraventricular tachycardia mimicking ventricular tachycardia during flecainide treatment
2. Sequential bilateral bundle branch block during dofetilide, a new class III antiarrhythmic agent, in a patient with atrial fibrillation
3. Comparison in the same patient of aberrant conduction and bundle branch reentry after dofetilide, a new selective class III antiarrhythmic agent
4. Effects of almokalant in atrial fibrillation and flutter
5. Efficacy and safety of dofetilide, a new class III antiarrhythmic agent, in acute termination of atrial fibrillation or flutter after coronary artery bypass surgery
6. Safety and risk/benefit analysis of ibutilide for acute conversion of atrial fibrillation/flutter
7. Electrophysiological and inotropic effects of H 234/09 (almokalant) in vitro: A comparison with two other novel IK blocking drugs, UK-68,798 (dofetilide) and E-4031
8. Proarrhythmic effects of the class III agent almokalant: Importance of infusion rate, QT dispersion, and early afterdepolarisations
9. Electrocardiographic and clinical predictors of torsades de pointes induced by almokalant infusion in patients with chronic atrial fibrillation or flutter: A prospective study
10. Spontaneous sequences of onset of torsade de pointes in patients with acquired prolonged repolarization: Quantitative analysis of Holter recordings
11. Almokalant-A selective class III antiarrhythmic compound
12. Effect of almokalant, a selective potassium channel blocker, on the termination and inducibility of paroxysmal supraventricular tachycardias: A study in patients with Wolff-Parkinson-White syndrome and atrioventricular nodal reentrant tachycardia
13. Electropharmacologic effects and pharmacokinetics of almokalant, a new class III antiarrhythmic, in patients with healed or healing myocardial infarcts and complex ventricular arrhythmias
14. Effects of the Ikr-blocker almokalant and predictors of conversion of chronic atrial tachyarrhythmias to sinus rhythm. A prospective study
15. An analysis of the time-relations of electrocardiograms
16. The differential morphology of anomalous ventricular complexes of RBBB-type in lead V1
17. Criteria, old, and new, for differentiating between ectopic ventricular beats and aberrant ventricular conduction in the presence of atrial fibrillation
18. The value of the electrocardiogram in the differential diagnosis of a tachycardia with a widened QRS complex
19. The differentiation between ventricular tachycardia and supraventricular tachycardia with aberrant conduction: The value of the 12-lead electrocardiogram
20. Electrocardiographic criteria for ventricular tachycardia in wide complex left bundle branch block morphology tachycardias
21. A new approach to the differential diagnosis of a regular tachycardia with a wide QRS complex
22. Electrophysiologic and hemodynamic effects of H 234/09 (almokalant), quinidine, and (+)-sotalol in the anesthetized dog
23. Torsades de pointes with Almokalant, a new class III antiarrhythmic drug
24. Chemical cardio version of atrial fibrillation with intravenous dofetilide
25. Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: A dose-response study
26. Torsades de pointes induced by transesophageal atrial stimulation after administration of almokalant
27. Sex difference in risk of torsade de pointes with d,I-sotalol
28. JTc prolongation with d,I-sotalol in women versus men